Mutation of serines 104, 106, and 118 inhibits dimerization of the human estrogen receptor in yeast

被引:15
|
作者
Sheeler, CQ [1 ]
Singleton, DW [1 ]
Khan, SA [1 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Vontz Ctr Mol Studies, Cincinnati, OH 45267 USA
关键词
estrogen receptor; phosphorylation; dimerization; MAP kinase; transactivation; yeast two-hybrid;
D O I
10.1081/ERC-120022321
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ligand-dependent dimerization and phosphorylation participate in regulating transcriptional activation of the estrogen receptor-alpha (ER). We investigated the role of serines 104, 106, and 118 located in the activation function-1 (AF-1) domain of ER in ligand-induced receptor dimerization. These serines, previously documented as important sites for transactivation, were mutated to alanine, and yeast genetic systems were used to determine their effect on receptor dimerization and transcriptional activity. The serine to alanine mutants resulted in 50-80% decreased dimerization in response to 17beta-estradiol, while having modest effects on ER-mediated transactivation. We further demonstrated that ER expressed in yeast became hyperphosphorylated in the presence of estradiol, most likely at a site(s) different than the serines under investigation. Ligand-induced phosphorylation was inhibited by U0126 indicating that the ER was phosphorylated via the MAPK pathway. Taken together, these data indicate that serines 104, 106, and 118 are important for ligand-dependent ER dimerization, and that MAP kinase mediated phosphorylation may be important for ER function, in yeast model systems.
引用
收藏
页码:237 / 255
页数:19
相关论文
共 50 条
  • [21] ESTRADIOL AND PHORBOL ESTER CAUSE PHOSPHORYLATION OF SERINE-118 IN THE HUMAN ESTROGEN-RECEPTOR
    JOEL, PB
    TRAISH, AM
    LANNIGAN, DA
    MOLECULAR ENDOCRINOLOGY, 1995, 9 (08) : 1041 - 1052
  • [22] Phospho-serine-118 estrogen receptor-α detection in human breast tumors in vivo
    Murphy, L
    Cherlet, T
    Adeyinka, A
    Niu, YL
    Snell, L
    Watson, P
    CLINICAL CANCER RESEARCH, 2004, 10 (04) : 1354 - 1359
  • [23] Phospho-serine 118 estrogen receptor-α in human breast tumors in vivo.
    Cherlet, TC
    Adeyinka, A
    Niu, Y
    Snell, L
    Watson, P
    Murphy, L
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S169 - S169
  • [24] HUMAN ESTROGEN-RECEPTOR REGULATION IN A YEAST MODEL SYSTEM AND STUDIES ON RECEPTOR AGONISTS AND ANTAGONISTS
    LYTTLE, CR
    DAMIANMATSUMURA, P
    JUUL, H
    BUTT, TR
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1992, 42 (07): : 677 - 685
  • [25] YEAST 2-HYBRID SYSTEM DEMONSTRATES THAT ESTROGEN-RECEPTOR DIMERIZATION IS LIGAND-DEPENDENT IN-VIVO
    WANG, H
    PETERS, GA
    ZENG, X
    TANG, ML
    WALLACE, I
    KHAN, SA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) : 23322 - 23329
  • [26] Celastrol inhibits the growth of estrogen positive human breast cancer cells through modulation of estrogen receptor α
    Jang, Soon Young
    Jang, Sung-Wuk
    Ko, Jesang
    CANCER LETTERS, 2011, 300 (01) : 57 - 65
  • [27] Deguelin inhibits the expression of estrogen receptor alpha in human breast cancer cells
    Alimirah, Fatouma
    Mehta, Rajeshwari R.
    Peng, Xinjian
    Mehta, Rajendra G.
    CANCER RESEARCH, 2012, 72
  • [28] PROMOTER SPECIFICITY OF THE 2 TRANSCRIPTIONAL ACTIVATION FUNCTIONS OF THE HUMAN ESTROGEN-RECEPTOR IN YEAST
    METZGER, D
    LOSSON, R
    BORNERT, JM
    LEMOINE, Y
    CHAMBON, P
    NUCLEIC ACIDS RESEARCH, 1992, 20 (11) : 2813 - 2817
  • [29] CLONING OF FULL-LENGTH HUMAN ESTROGEN RECEPTOR AND CONSTRUCTION OF THE EXPRESSION VECTOR IN YEAST
    Zheng Chenna
    Yang Huiyong
    Li Qingsong
    Yang Li
    Zeng Shulan
    Diao Yong
    PROGRESS ON POST-GENOME TECHNOLOGIES AND MODERN NATURAL PRODUCTS, 2011, 2011, : 263 - 265
  • [30] A point mutation in the human estrogen receptor gene is associated with the expression of an abnormal estrogen receptor mRNA containing a 69 novel nucleotide insertion
    M. Wang
    H. Dotzlaw
    S.A.W. Fuqua
    L.C. Murphy
    Breast Cancer Research and Treatment, 1997, 44 : 145 - 151